Ischemia of the Eye on the Background of Primary Hypothyroidism and Primary Thyrotoxicosis

Purpose: to study the features of the blood filling of the eye in patients with primary untreated hypothyroidism and primary untreated thyrotoxicosis by plethysmography. Materials and methods. The material of the study was the results of a comprehensive examination of 43 patients (86 eyes): 23 people (46 eyes) with primary untreated hypothyroidism and 20 people (40 eyes) with primary untreated hyperthyroidism. The ocular blood flow was assessed by ophthalmoplethysmography. Results. The obtained plethysmography data confirm that even in the absence of endocrine ophthalmopathy in patients with primary untreated hypothyroidism and primary untreated thyrotoxicosis, deep hemodynamic disturbances in the major vessels of the eye develop leading to ischemia of its anterior and posterior parts, which can lead to hydrodynamic disturbances in the eye, sensitivity of the visual analyzer to ischemia and hypoxia and to promote the development of secondary optic neuropathy. In this study, a significant reduction of 30–40 % from the norm of volume and consumption indicators of the blood filling of the eye with impaired placement of blood in the choriocapillaries, reduced elasticity of the choroidal vessel wall was detected, which can not but trigger the development of various pathological processes. For example, ischemia of the ciliary body and the trabecular meshwork, the presence of thyroid receptors on endothelial and smooth muscle cells of choroidal and orbital vessels, can lead to hydrodynamic disturbances, and ischemia of the optic nerve, which arises due to violation peripapillary flow having choroidal source of blood supply, can result in an optical neuropathy. In this aspect, thyroid disease is associated with an increased risk of developing glaucoma, endocrine ophthalmopathy. The conclusion. Despite the constant expansion of various innovative dopplerographic systems, plethysmography — as a method of examining the blood filling of the eye, remains in demand, reliable and highly informative. In patients with uncompensated thyroid dysfunctions, a violation of the blood supply to the anterior segment of the eye is observed, which can cause a low effect of antihypertensive monotherapy in the treatment of glaucoma.

1. Киселева Т.Н., Пантелеева О.Г., Шамшинова А.М. Кровоток в сосудах глаза и орбиты у больных эндокринной офтальмопатией. Вестник офтальмологии. 2007;(1):33–36. [Kiseleva T.N., Panteleeva O.G., Shamshinova A.M. The blood flow in the vessels of the eye and orbit in patients with endocrine ophthalmopathy. Annals of Ophthalmology = Vestnik oftal’mologii. 2007;(1):33–36 (In Russ.)].

2. Дедов И.И. Болезнь Грейвса и эндокринная офтальмопатия. М.: МАИ-Принт; 2012. [Dedov I.I. Graves Disease and Endocrine Ophthalmopathy. Moscow: GEO TAR-media; 2007 (In Russ.)].

3. Wiersinga W.M., Kahaly G.J. Graves’ Orbitopathy. Basel: Karger; 2007.

4. McKeag D. Clinical features of dysthyroid optic neuropathy: a European Group on Graves’ Orbitopathy (EUGOGO). Br. J. Ophthalmol. 2007;91:455–458. DOI: 10.1136/bjo.2006.094607

5. Лихванцева В.Г., Харлап С.И., Коростелёва Е.В., Соломатина М.В. Гемодинамические нарушения в магистральных сосудах глаза и орбиты при эндокринной офтальмопатии как фактор риска развития оптической нейропатии. Национальный журнал Глаукома. 2014;(3):14–27. [Likhvantseva V.G., Harlap S.I., Korosteleva E.V., Solomatina M.V. Hemodynamic Disturbances in Magistral Eye Vessels and Orbit in Endocrine Ophthalmopathy as a Risk Factor in the Development of Optic Neuropathy. National Journal of Glaucoma = Natsional´nyi zhurnal glaucoma. 2014;(3):14–27 (In Russ.)]. DOI: 10.17116/oftalma2015131432-37

6. He J. Clinical analysis of 106 cases with elevated intraocular pressure in thyroidassociated ophthalmopathy. Yan Ke Xue Bao. 2004;20(1):10–14.

7. Klein I., Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725– 1735. DOI: 10.1161/CIRCULATIONAHA.106.678326

8. Everett A., Umeda P., Sinha A., Jakovcic S., Rabinowitz M., Zak R. Expression of myosin heavy chains during thyroid hormone-induced cardiac growth. Fed. Proc. 1986;45:2568–2572.

9. Rohrer D., Dillman W. Thyroid hormone markedly increases the mRNA coding for sarcoplasmic reticulum Ca2+-ATPase in the rat heart. J. Biol. Chem. 1988;263:6941– 6944.

10. Ojamaa K., Kenessey A., Klein I. Thyroid hormone regulation of phospholamban phosphorylation in the rat heart. Endocrinol. 2000;141:2139. DOI: 10.1210/ endo.141.6.7514

11. Fazio S., Palmieri E.A., Lombardi G., Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent Progress in Hormone Research. 2004;59:31–50.

12. Fukuyama K., Ichiki T., Takeda K., Tokunou T., Iino N., Masuda S., Ishibashi M., Egashira K., Shimokawa H., Hirano K., Kanaide H., Takeshita A. Down regulation of vascular angiotensin II type 1receptor by thyroid hormone. Hypertension. 2003;41:598–603. DOI: 10.1161/01.HYP.0000056524.35294.80

13. Davis P.J., Leonard J.L., Davis F.B. Mechanisms of nongenomic actions of thyroid hormone. Frontiers in Neuroendocrinol. 2008;29:211–218. DOI: 10.1016/j. yfrne.2007.09.003

14. Biondi B., Palmieri E., Lombardi G., Fazio S. Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J. Clin. Endocrinol. Metab. 2002;87:968. DOI: 10.1210/jcem.87.3.8302

15. Лихванцева В.Г., Кузьмин К.А., Коростелёва Е.В., Соломатина М.В., Буданова С.В. Поиск и идентификация рецепторов тиреоидных гормонов в тканях глаза. Офтальмология. 2014;2(11):27–30. [Likhvantseva V.G., Kuzmin K.A., Korosteleva E.V., Solomatina M.V., S.V. Budanova. Search and identification of thyroid hormone receptor in tissues of the eye. Ophthalmology in Russia = Oftal’mologiya. 2014;2(11):27–30 (In Russ.)]. DOI: 10.18008/1816-5095-2014-2-27-31

16. Лихванцева В.Г., Коростелева Е.В., Ковеленова И.В., Буданова С.В., Бен Режеб Амин. Дефицит глазного кровотока — ключевой фактор, определяющий форму вторичной глаукомы при эндокринной офтальмопатии. Российский офтальмологический журнал. 2016;9(3):43–49. [Likhvantseva V.G., Korosteleva E.V., Kovelenova I.V., Budanova S.V., Ben Rezheb Amin. Deficiency of eye blood flow as a key factor determining the form of secondary glaucoma in endocrine ophthalmopathy. Russian Ophthalmological Journal = Rossijskij Oftal’mologicheskij Zhurnal. 2016;9(3):43–49 (In Russ.)]. DOI: 10.1016/0014-4835(92)90793-r